RecruitingPhase 4NCT04376216
Prednisolone Treatment in Acute Interstitial Nephritis
Prednisolon Behandling Ved Akut Interstitiel Nefritis - et Randomiseret, Prospektivt Studie
Sponsor
Region MidtJylland Denmark
Enrollment
110 participants
Start Date
Sep 1, 2017
Study Type
INTERVENTIONAL
Conditions
Summary
A Prospective randomized trial with a primary objective to investigate the effect ofprdenisolone treatment in acute interstitial nephritis
Eligibility
Min Age: 18 Years
Plain Language Summary
Simplified for easier understanding
This clinical trial is studying a drug called Prednisone for people with acute tubulo-interstitial nephritis. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DRUGPrednisone
60 mg with dose tapering over 2 months
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04376216